MedTrace Logo

Cardiometabolic Syndrome Response to Therapeutic Lifestyle Changes

NCT04093440 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2019-09-18

No results posted yet for this study

Summary

Intensive lifestyle intervention has shown to be effective in high risk patient populations and has gathered support from leaders-as outlined in the 2015 consensus paper by the Cardiometabolic Health Alliance. Thus there has been a call to establish new care models that assist Metabolic Syndrome patients in reducing there risk. The investigators aim to evaluate the impact of a lifestyle intervention program on metabolic syndrome patients.

Conditions

  • Metabolic Syndrome
  • ASCVD
  • Lifestyle Risk Reduction

Interventions

OTHER

lifestyle modification

nutrition counselling, diet and physical exercise monitoring, smoking cessation, and medication optimization

Sponsors & Collaborators

  • Holy Cross Hospital, Florida

    lead OTHER

Principal Investigators

  • Charles Russo, MD · Jim Moran Heart and Vascular Research Center at Holy Cross Hospital

  • Paul Papagni, JD · Jim Moran Heart and Vascular Research Center at Holy Cross Hospital

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-31
Primary Completion
2020-10-31
Completion
2021-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04093440 on ClinicalTrials.gov